Skip to main navigation Skip to search Skip to main content

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy

Project: Research

Project Details

StatusFinished
Effective start/end date10/28/1303/17/16

Funding

  • Auxilium Pharmaceuticals: $52,342.00